Skip to main content
Fig. 5 | Particle and Fibre Toxicology

Fig. 5

From: Group II innate lymphoid cells and microvascular dysfunction from pulmonary titanium dioxide nanoparticle exposure

Fig. 5

Pre-treatment of nano-TiO2 – exposed animals with an anti-IL-33 antibody lowers BALF and plasma IL-33. Interleukin-33 levels in (a) BALF and (b) plasma in control, nano-TiO2 exposed groups and in rats pre-treated with an anti-IL-33 antibody. Rats were pre-treated with an anti-IL-33 antibody (1 mg/kg) 30 min prior to exposure. Plasma and BALF IL-33 levels were measured 4 h post-exposure. Statistics were analyzed with two-way ANOVA (P ≤ 0.05). * Sham control group vs. nano-TiO2 exposed groups, Ŧ P < 0.05 Exposed + Anti-IL-33 Antibody vs Exposed

Back to article page

Particle and Fibre Toxicology

ISSN: 1743-8977

Contact us